Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cowealth Medical Holding CoROCO:4745 53 Cash Ratio is 0.29 as of Jun. 2026, which is 45% below its 10-year median of 0.53. GuruFocus rates ROCO:4745 with a GF Score™ of 53/100 and a GF Value™ of NT$14.08 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 834 Medical Devices & Instruments companies, Cowealth Medical Holding Co ranks worse than 76.62% on this metric.
Cowealth Medical Holding Co has a Cash Ratio of 0.29. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.
The historical rank and industry rank for Cowealth Medical Holding Co's Cash Ratio or its related term are showing as below:
ROCO:4745'
s Cash Ratio Range Over the Past 10 Years
Min: 0.13 Med: 0.53 Max: 1.18
Current: 0.29
During the past 13 years, Cowealth Medical Holding Co's highest Cash Ratio was 1.18. The lowest was 0.13. And the median was 0.53.
ROCO:4745's Cash Ratio is ranked worse than 76.62% of 834
companies
in the Medical Devices & Instruments industry
Industry Median: 0.945
vs ROCO:4745: 0.29
Cowealth Medical Holding Co (ROCO:4745) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Cowealth Medical Holding Co Cash Ratio Related Terms
Cowealth Medical Holding Co Cash Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Cowealth Medical Holding Co's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cowealth Medical Holding Co Cash Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Cowealth Medical Holding Co's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Cowealth Medical Holding Co's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cowealth Medical Holding Co (ROCO:4745) has a Cash Ratio of 0.29 as of Jun. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Cowealth Medical Holding Co and its competitors. This is 45% below median its historical median of 0.53. Over the past decade, Cowealth Medical Holding Co's Cash Ratio has ranged from 0.13 to 1.18. According to the industry distribution chart, Cowealth Medical Holding Co ranks #639 out of 834 companies in the Medical Devices & Instruments industry, placing it in the top 76.6%.
Is Cowealth Medical Holding Co's Cash Ratio too high?
Cowealth Medical Holding Co's current Cash Ratio of 0.29 is 45% below median its 10-year median of 0.53. Over the past 10 years, this metric has ranged from a low of 0.13 to a high of 1.18. The Medical Devices & Instruments industry median Cash Ratio is 0.95. Cowealth Medical Holding Co's value of 0.29 is 69.3% below this industry median. Based on the distribution chart, Cowealth Medical Holding Co ranks #639 out of 834 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Cowealth Medical Holding Co has a GF Score™ of 53/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cowealth Medical Holding Co's Cash Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Cowealth Medical Holding Co ranks #639 out of 834 companies for Cash Ratio. This places Cowealth Medical Holding Co in the lower half of its industry. The industry median Cash Ratio is 0.95. Cowealth Medical Holding Co's value of 0.29 is 69.3% below this benchmark. Historically, Cowealth Medical Holding Co's own Cash Ratio has ranged from 0.13 to 1.18 over the past decade. While the company's 10-year median is 0.53 vs. the industry median of 0.95, Cowealth Medical Holding Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Medical Devices & Instruments company?
The median Cash Ratio among Medical Devices & Instruments companies is 0.95, based on 834 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cowealth Medical Holding Co's current Cash Ratio of 0.29 is 69.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Cowealth Medical Holding Co and its competitors. For the Medical Devices & Instruments industry, the median Cash Ratio is 0.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cowealth Medical Holding Co's current Cash Ratio is 0.29, which is 45% below median its own 10-year median of 0.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cowealth Medical Holding Co stock overvalued right now?
Based on GuruFocus' analysis, Cowealth Medical Holding Co (ROCO:4745) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$14.08, compared to a current price of NT$11.70 — trading 16.9% below its estimated fair value. The current Cash Ratio is 0.29, which is 45% below median its 10-year median of 0.53 and 69.3% below the Medical Devices & Instruments industry median of 0.95. Cowealth Medical Holding Co's overall GF Score™ is 53/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Cowealth Medical Holding Co (ROCO:4745), the current Cash Ratio is 0.29 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cowealth Medical Holding Co (ROCO:4745) Overvalued in 2026?
Based on GuruFocus' analysis, Cowealth Medical Holding Co stock appears to be undervalued.
The current stock price of NT$11.70 is trading 16.9% below its estimated GF Value™ of NT$14.08.
GuruFocus considers Cowealth Medical Holding Co to be Modestly Undervalued.
Key valuation signals for ROCO:4745:
Cash Ratio: 0.29 (45% below median its 10-year median of 0.53)
GF Value™: NT$14.08 vs. price of NT$11.70 (16.9% below fair value)
Industry Position: 69.3% below the Medical Devices & Instruments median (#639 of 834)
No single metric tells the full story. See the ROCO:4745 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cowealth Medical Holding Co Ltd is mainly involved in trading medical equipment, reagents, and spare parts. Its wide range of solutions includes refined management services tailored for in-vitro diagnostic products, reagents, and consumables, an integrated platform designed for decision-making and analysis, commercialization of achievements in medical science and technology, a Multi-Channel Coaxial Time Audio Video Imaging Platform (MCCTAVIP), and an AI-assisted system for clinical diagnosis. The Group has two reportable segments: Segment A, which generates maximum revenue and sells equipment, and Segment B, which sells reagents and others. Geographically, it generates maximum revenue from China and Hong Kong, and the rest from Taiwan.
53GF Score
Get the complete analysis for ROCO:4745
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4745 has been successfully added to your 
